ENTA
Enanta Pharmaceuticals Inc
12.40$
+1.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.5% | 91.1% | 84.9% | 71.9% | 79.6% | 76.9% | 75.2% | 74.0% | 72.8% | 60.3% | 56.7% | 68.6% | |
| 18.5% | 9.3% | 15.4% | 9.0% | 9.9% | 24.2% | 18.6% | 14.9% | 11.5% | 11.4% | 11.1% | 11.3% | |
| 80.0% | 78.7% | 72.6% | 57.7% | 65.9% | 62.2% | 59.9% | 67.8% | 67.3% | 56.4% | 52.0% | 63.8% | |
| 8.6% | 9.3% | 9.6% | 10.2% | 10.3% | 11.5% | 12.6% | 2.8% | 2.5% | 2.6% | 2.5% | 2.2% | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 53.1% | 55.2% | 59.8% | 62.7% | 65.8% | 67.9% | 71.0% | 73.7% | 76.9% | 61.6% | 63.0% | 66.0% | |
| 13.6% | 14.6% | 13.2% | 14.6% | 15.3% | 14.1% | 14.2% | 14.8% | 17.3% | 13.6% | 14.8% | 18.2% | |
| 8.7% | 10.8% | 9.0% | 8.7% | 9.6% | 9.7% | 10.2% | 10.0% | 12.1% | 10.7% | 11.2% | 1.3% | |
| 0.9% | 2.2% | 1.6% | 2.7% | 2.1% | 1.4% | 1.5% | 1.2% | 0.7% | 0.6% | 1.4% | 1.1% | |
| 46.9% | 44.8% | 40.2% | 37.3% | 34.2% | 32.1% | 29.0% | 26.3% | 23.1% | 38.4% | 37.0% | 34.0% | |
| -44.8% | -56.1% | -65.7% | -73.8% | -85.8% | -99.1% | -113.9% | -128.3% | -144.2% | -126.5% | -136.6% | -151.4% | |
| 4.6% | 4.9% | 5.1% | 5.3% | 5.6% | 6.1% | 6.6% | 7.1% | 7.6% | 8.7% | 9.2% | 9.8% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.